Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2000
06/28/2000EP1012174A1 Nik proteins, nucleic acids and methods
06/28/2000EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
06/28/2000EP1012162A4 Soluble proteins
06/28/2000EP1012162A1 Soluble proteins
06/28/2000EP1012161A1 High fidelity polymerases and uses thereof
06/28/2000EP1012160A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides
06/28/2000EP1012158A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase
06/28/2000EP1012157A1 $i(BORRELIA BURGDORFERI) POLYNUCLEOTIDES AND SEQUENCES
06/28/2000EP1012156A2 AMINO ACID SEQUENCES AND METHOD FOR ISOLATING BACTERIES FROM THE TYPE GENUS $i(PSEUDOMONAS)
06/28/2000EP1012155A1 Human uncoupling protein 3
06/28/2000EP1011864A1 Apparatus for a fluid impingement thermal cycler
06/28/2000EP1011735A1 METHOD OF $i(IN VIVO) TRANSFORMATION UTILIZING LIPID VEHICLES
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
06/28/2000EP1011723A1 88kda tumorigenic growth factor and antagonists
06/28/2000EP1011717A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
06/28/2000EP1011703A1 Nucleosome-based anti-tumor compositions
06/28/2000EP1011655A1 Inhibitors of leaderless protein export
06/28/2000EP1011608A2 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
06/28/2000EP1011328A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
06/28/2000EP1011320A1 Transplacental delivery of oligonucleotides
06/28/2000EP1011319A1 A method of treatment and an animal model useful for same
06/28/2000EP1011311A1 Controlled germination using inducible phytate gene
06/28/2000EP1011310A2 Method for large scale mutagenesis in crop plants
06/28/2000EP0866719B1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product
06/28/2000EP0833899A4 Cis-9,10-octadecenoamidase
06/28/2000EP0739356B1 Polyclonal antibody to pna/nucleic acid complexes
06/28/2000EP0707655B1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy
06/28/2000EP0639224B1 Lectin domain variants of selectin
06/28/2000EP0557418B1 A beta-type transforming growth factor
06/28/2000CN1258320A Taqmantm-PCR for detection of pathogenic E coli strains
06/28/2000CN1258319A Vector
06/28/2000CN1258318A Selection marker
06/28/2000CN1258317A Process for expression of genes of dengue viruses
06/28/2000CN1258316A Plant transformation methods
06/28/2000CN1258315A Mammalian cytokine-like factor-7
06/28/2000CN1257929A Ribosome S6 protein kinase
06/28/2000CN1257928A Efficient expression of human retinol-binding protein gene and its special primer
06/28/2000CN1257927A Human protein and its coding sequence, preparing process and usage
06/28/2000CN1257926A Human protein and its coding sequence, preparing process and usage
06/28/2000CN1257925A Human galactoside transferase I-type homogenous protein
06/28/2000CN1257924A Human Ras correlative GTP bindin kinase
06/28/2000CN1257923A RaL GTP guanine dissociation stimulator
06/28/2000CN1257922A Cytokine signal transfer arrestin IV
06/28/2000CN1257921A Human melanoma growth correlation factor and its coding sequence, preparing process and usage
06/28/2000CN1257920A Human melanoma growth correlation factor and its coding sequence, preparing process and usage
06/28/2000CN1257919A Hepatitis B virus protein bound arrestin
06/28/2000CN1257918A Recombination antifungus protein gene sequence, engineering bacterium and process for preparing its products
06/28/2000CN1257917A Amylase
06/28/2000CN1257872A Leptospiral vaccine antigen for preventing leptospirosis
06/28/2000CN1053925C Activator of tissue-type plasminogen
06/28/2000CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition
06/27/2000USRE36755 DNA encoding tumor necrosis factor-α and -β receptors
06/27/2000US6080920 Transgenic plants exhibiting altered flower color and methods for producing same
06/27/2000US6080915 Constructs encoding degradation enzymes for aromatic compounds and transgenic plants containing same
06/27/2000US6080914 Strawberry promoters and genes
06/27/2000US6080913 Binary methods of increasing accumulation of essential amino acids in seeds
06/27/2000US6080912 Methods for creating transgenic animals
06/27/2000US6080911 Mice models of growth hormone insensitivity
06/27/2000US6080910 Transgenic mouse comprising a genome with a homozygous disruption of the immunoglobulin gamma 3 gene; for screening compounds for immunizing activity
06/27/2000US6080868 As a quencher in a reporter-quencher energy-transfer dye pair for nucleic acid hybridization assays
06/27/2000US6080851 Ribozymes with linked anchor sequences
06/27/2000US6080850 Nucleotide sequence of s gene with modified major enhancing epitopes; for vaccines without accelerated progression of disease
06/27/2000US6080844 Process for the recovery and purification of a recombinant protein from a cell
06/27/2000US6080842 Amino acid sequence; for anticarcinogenic/antitumor agents and treatment of nervous system disorders such as alzheimer's/parkinson's/huntington's diseases; antiepileptic agents; cognition activators; antidepressants
06/27/2000US6080841 Human induced tumor protein
06/27/2000US6080729 Polypeptides and polynucleotides used to screen for antibacterial compounds
06/27/2000US6080728 Inhibiting tumor growth
06/27/2000US6080727 Oligonucleotide treatments and compositions for human melanoma
06/27/2000US6080724 Peptides which can be used as vectors for the intracellular addressing of active molecules
06/27/2000US6080723 Human actVA-ORF4-like protein
06/27/2000US6080718 Useful in the identification and isolation of components involved in transmembrane receptor-mediated signaling
06/27/2000US6080717 Treatment of individual having a need to inhibit a polypeptide, comprising administering a bactericidal antagonist of the polypeptide
06/27/2000US6080582 Cell tests for Alzheimer's disease
06/27/2000US6080580 Antiinflammatory/antidiabetic/antiarthritic agents; diagnosis and therapy of inflammation and autoimmune diseases; rheumatoid arthritis, crohn's disease, pancreatitis, multiple sclerosis, atopic dermatitis, hepatitis
06/27/2000US6080578 Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia
06/27/2000US6080577 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy
06/27/2000US6080576 Vectors for gene trapping and gene activation
06/27/2000US6080575 Isolated nucleic acid construct for expressing a biologically active substance which is activated by an enzyme released from mammalian cells; for target cell-specific therapy for tumors and inflammation
06/27/2000US6080569 Adenovirus vectors generated from helper viruses and helper-dependent vectors
06/27/2000US6080568 Mutant α-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus licheniformis
06/27/2000US6080567 Enzymes with xylanase activity from Aspergillus aculeatus
06/27/2000US6080566 Mixture of ammonium ion and a recombinantly produced organophosphorus acid anhydrolase 2 from alteromonas; for biodegradation of stocks of cholinesterase-inhibiting pesticides and chemical nerve agents
06/27/2000US6080560 Method for producing antibodies in plant cells
06/27/2000US6080559 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
06/27/2000US6080558 Polynucleotide encoding human growth regulator protein
06/27/2000US6080556 Dna coding for specific amino acid sequences; for detection of gene in samples using polymerase chain reaction
06/27/2000US6080555 Incubating a genetically engineered polyketide synthase modified by deactivation of catalytic domain of ketosynthase of first module with diketide substrate and optionally recovering the produced polyketide; for generating libraries
06/27/2000US6080553 Creatine amidinohydrolase, production thereof and use thereof
06/27/2000US6080550 Isolation and characterization of Agouti: a diabetes/obesity related gene
06/27/2000US6080548 Amino acid sequences; screening a library for compounds that bind the polypeptide including peptides, antibodies, inhibitors, drug compounds, and pharmaceutical agents
06/27/2000US6080547 Distinguishing between species by identifying a selected campylobacter dna sequence and testing for presence of one or more restriction endonuclease sites to classify species jejuni, coli, upsaliensis, and lari
06/27/2000US6080546 Antisense modulation of MEKK5 expression
06/27/2000US6080545 Oligonucleotides for the detection of salmonella
06/27/2000US6080542 Plant peptide transport gene
06/27/2000US6080541 Producing tagged gene by inserting dna sequence into intron of gene, incubating within eucaryotic cell for gene expression, contacting with binding reagent specific for produced peptide tag, separating from other parts of cell
06/27/2000US6080540 Expressing mammalian gene in a recombinant microorganism causing modified phenotype associated with mutation, incubating with chemical, determining if altered phenotype is reversed indicating that agent suppresses the mammalian gene
06/27/2000US6080409 Immunostimulatory method
06/27/2000US6080408 Particles contain mutations to reduce gag-dependent rna-packaging of the gag gene product, eliminate reverse transcriptase, integrase activity and rnase h activity of the pol gene product through genetic manipulation; vaccines; aids
06/27/2000US6080407 Diagnostic assays for MIF
1 ... 3224 3225 3226 3227 3228 3229 3230 3231 3232 3233 3234 3235 3236 3237 3238 3239 3240 3241 3242 3243 3244 ... 4023